Philip is a partner in Haiwen Hong Kong office.  Philip has long been engaged in legal services including Hong Kong company law, listing rule, capital market transactions and cross-border mergers and acquisitions. Philip has extensive experience in Hong Kong capital market transactions and cross-border mergers and acquisitions. He has assisted clients in pre-IPO financing, listing, post-IPO compliance, control transfer, and privatization in various capital market transactions. In particular, he works on initial public offerings and post-listing mergers and acquisitions and compliance involving issuers in China (including H shares and red chips) and overseas backgrounds, as well as work related to the Hong Kong Stock Exchange's Listing Rules and the Securities and Futures Commission's Takeovers and Mergers Code.

Philip has accumulated more than 16 years of experience in leading companies and law firms, and was awarded the honor of "40 Under 40" by LexisNexis, a well-known legal institute LexisNexis in 2022. Prior to joining Haiwen, Philip was the General Counsel of a Hong Kong-listed company with market capitalisation of over HK$10 billion, responsible for the company's legal matters and advising on the legal aspects of compliance, investigation, investment/divestment transactions. Previously, Philip was a Senior Legal Counsel of a Fortune 500 company and a Consultant at Clifford Chance in Shanghai and Hong Kong for more than 10 years, where he accumulated extensive experience in the industry.

Philip's recent experience includes advising: 

•  the transfer of the controlling stake of HKICIM Group and the triggering of a Mandatory General Offer under the Takeovers and Mergers Code;

•  a family fund invested in Terminus (an AI business company) as a private equity investor;

•  CDB International Investment Limited sold a 29.99% stake in China New Town, a Hong Kong-listed real estate company (obtaining confirmation from the Securities and Futures Commission that it would not trigger a Mandatory General Offer under the Takeovers and Mergers Code);

•  China Mobile's investment in a Hong Kong-listed software company, which may trigger Hong Kong's Takeovers Code obligations to provide advice and represent it in negotiations with the Hong Kong Securities and Futures Commission;

•  Clarity Medical on its listing and global offering in Hong Kong;

•  Genor Biopharma (holding company of Hillhouse Capital) on its listing and global offering in Hong Kong;

•  Morgan Stanley Private Equity in the listing and global offering of its wholly-owned investee company Home Control on the Hong Kong Stock Exchange;

•  Morgan Stanley Private Equity obtained an overseas M&A loan and acquired equity in a domestic company;

•  ChemChina: Advising on the restructuring of Syngenta Group, ChemChina and Sinochem Corporation and the acquisition of a controlling stake in Hong Kong-listed Sinochem Hong Kong Holdings Limited;

•  various transactions with Blackstone, Henderson Land, Wheelock Property and other prominent counterparties for aggregated consideration of over US$3 billion; regulators’ queries, compliance to applicable laws and rules, various financing and refinancing transactions, etc;

•  HNA Foods: advising on its proposed acquisition of a Hong Kong-listed food company and making a general offer;

•  HNA Investment: Advising on its proposed acquisition of a controlling stake in a Hong Kong-listed financial sector company through a voluntary partial tender offer;

•  China Mobile's investment in a Hong Kong-listed H-share company;

•  Hong Kong International Construction Investment (687.hk) invested in Hong Kong Airlines;

•  the sponsors in the spin off and Hong Kong listing of BOCOM International Holdings Company Limited;

•  VPower, a Hong Kong-based international power solutions company on its listing and global offering in Hong Kong;

•  China Resources Pharmaceutical on its listing and global offering in Hong Kong;

•  China Huarong's investment in MI Energy, an energy company, was restructured;

•  a transaction in which an affiliate of China Travel Service International increased its capital in China National Tourism Administration;

•  major transaction in which China General Nuclear Power Co., Ltd. acquired the assets of China General Nuclear Power Group for approximately RMB10 billion;

•  well-known companies such as China National Offshore Oil Corporation, COFCO, Beijing Enterprises Holdings, KKR, CICC Capital, Sequoia Capital, and China Life Fund for analysis and transactions under Hong Kong law;

•  BAML and UBS in the approximately US$1.2 billion global offering and Hong Kong listing of Everbright Securities;

•  CICC, BAML and ABCI in the Hong Kong listing and global offering of CGN Power Co., Ltd. of approximately US$3 billion. CGN Power is the first and only nuclear power operator listed on the Hong Kong Stock Exchange;

•  BOCI, CCBI and ABCI in the approximately US$1 billion global offering and Hong Kong listing of Bank of Tianjin;

•  the sponsors in the approximately US$8 billion global offering and Hong Kong listing of China Postal Savings Bank;

•  Morgan Stanley in the approximately US$200 million IPO and listing of PW Medtech Limited, a leading medical device company in China, on the Main Board of the Hong Kong Stock Exchange;

•  Morgan Stanley, UBS, J.P. Morgan, BOCI, CITIC in the approximately US$1.36 billion IPO and listing of Huishang Bank Corporation Limited, the largest city commercial bank in Anhui, China, on the Main Board of the Hong Kong Stock Exchange;

•  J.P. Morgan, Morgan Stanley and UBS, as underwriters, on the US$1.9 billion Hong Kong listing and Rule 144A global offering of Wynn Macau Limited, owner and operator of casinos and resorts;

•  the underwriters in the Hong Kong listing and global offering plan of an online gaming company in PRC with VIE structure;

•  J.P. Morgan on the listing of a mining subsidiary of Wuhan Iron and Steel (Group) Corporation;

•  Goldman Sachs and Morgan Stanley, as underwriters, on the US$450 million red-chip listing and Rule 144A global offering of Yingde Gases Group Company, a leading industrial gas supplier in China;

•  Kunlun Energy in respect of its very substantial acquisition of Petrochina Kunlun Gas for over US$2.3 billion;

•  on the top-up placing of Hong Kong-listed companies such as Sino Biopharmaceutical Limited, China Agri-Industries Holdings Limited, and Kunlun Energy, Real Gold Mining Limited;

•  New World Development on its potential large scale acquisition of a Grade-A property in Hong Kong;

•  Singamas on its application for whitewash exemption under the Takeovers Code from the Securities and Futures Commission of Hong Kong in connection with the rights issue;

•  NWS Holdings Limited in its pre-IPO investment in an infrastructure technology solutions company;

•  GIC Private Ltd in respect of its interests in China International Capital Corporation Limited;

•  China Construction Bank in its acquisition of AIG Finance (Hong Kong) Limited.

Philip received his Bachelor's degree in Business Administration (Law) and Bachelor's degree in Laws from University of Hong Kong. He is a qualified solicitor of Hong Kong SAR and England & Wales. Philip has also passed the lawyer examination in Guangdong-Hong Kong-Macao Greater Bay Area, China.

Chinese (Cantonese, Mandarin), English.